Evidence map›Paper›PMID 29378542›Full record

Trial reportBMC public health2018

Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol.

Yves-Nathan T Tian-Bi, Mamadou Ouattara, Stefanie Knopp, Jean T Coulibaly, Eveline Hürlimann, Bonnie Webster, Fiona Allan, David Rollinson, Aboulaye Meïté, Nana R Diakité and 3 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Effectiveness of Four Different Interventions Against Schistosoma haematobium in a Seasonal Transmission Setting of Côte d'Ivoire: A Cluster Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. The parasitology of female genital schistosomiasis.Current research in parasitology & vector-borne diseases · 2022
    Review
  11. Article
  12. Baseline and Impact of First-Year Intervention onTropical medicine and infectious disease · 2021
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Yves-Nathan T Tian-BiUnité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan, 22, Côte d'Ivoire. tianbyth@yahoo.fr.
Mamadou OuattaraUnité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan, 22, Côte d'Ivoire.
Stefanie KnoppSwiss Tropical and Public Health Institute, P.O. Box, CH-4002, Basel, Switzerland.
Jean T CoulibalyUnité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan, 22, Côte d'Ivoire.
Eveline HürlimannSwiss Tropical and Public Health Institute, P.O. Box, CH-4002, Basel, Switzerland.
Bonnie WebsterWolfson Wellcome Biomedical Laboratories, Department of Life Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD, United Kingdom.
Fiona AllanWolfson Wellcome Biomedical Laboratories, Department of Life Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD, United Kingdom.
David RollinsonWolfson Wellcome Biomedical Laboratories, Department of Life Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD, United Kingdom.
Aboulaye MeïtéProgramme National de Lutte contre les Maladies Tropicales Négligées à Chimiothérapie Préventive, Ministère de la Santé et de l'Hygiène Publique, 06 BP 6394, Abidjan, 06, Côte d'Ivoire.
Nana R DiakitéUnité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan, 22, Côte d'Ivoire.
Cyrille K KonanUnité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan, 22, Côte d'Ivoire.
Eliézer K N'GoranUnité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan, 22, Côte d'Ivoire.
Jürg UtzingerSwiss Tropical and Public Health Institute, P.O. Box, CH-4002, Basel, Switzerland. juerg.utzinger@swisstph.ch.
Natural History Museum · GBSwiss Tropical and Public Health Institute · CHUniversité Félix Houphouët-Boigny · CISwiss Centre for Scientific Research · CIInstitut National d’Hygiène Publique · CIUniversity of Basel · CH

Funding

Bill and Melinda Gates Foundation RR374-053/4893196Bill and Melinda Gates Foundation RR374-092/S000690Wellcome TrustWellcome Trust WT104958MA
6 · The paper itself

Abstract

backgroundTo achieve a world free of schistosomiasis, the objective is to scale up control and elimination efforts in all endemic countries. Where interruption of transmission is considered feasible, countries are encouraged to implement a comprehensive intervention package, including preventive chemotherapy, information, education and communication (IEC), water, sanitation and hygiene (WASH), and snail control. In northern and central Côte d'Ivoire, transmission of Schistosoma haematobium is seasonal and elimination might be achieved. In a cluster-randomised trial, we will assess different treatment schemes to interrupt S. haematobium transmission and control soil-transmitted helminthiasis over a 3-year period. We will compare the impact of (i) arm A: annual mass drug administration (MDA) with praziquantel and albendazole before the peak schistosomiasis transmission season; (ii) arm B: annual MDA after the peak schistosomiasis transmission season; (iii) arm C: two yearly treatments before and after peak schistosomiasis transmission; and (iv) arm D: annual MDA before peak schistosomiasis transmission, coupled with chemical snail control using niclosamide. METHODS/

designThe prevalence and intensity of S. haematobium and soil-transmitted helminth infections will be assessed using urine filtration and Kato-Katz thick smears, respectively, in six administrative regions in northern and central parts of Côte d'Ivoire. Once a year, urine and stool samples will be collected and examined from 50 children aged 5-8 years, 100 children aged 9-12 years and 50 adults aged 20-55 years in each of 60 selected villages. Changes in S. haematobium and soil-transmitted helminth prevalence and intensity will be assessed between years and stratified by intervention arm. In the 15 villages randomly assigned to intervention arm D, intermediate host snails will be collected three times per year, before niclosamide is applied to the selected freshwater bodies. The snail abundance and infection rates over time will allow drawing inference on the force of transmission. DISCUSSION: This cluster-randomised intervention trial will elucidate whether in an area with seasonal transmission, the four different treatment schemes can interrupt S. haematobium transmission and control soil-transmitted helminthiasis. Lessons learned will help to guide schistosomiasis control and elimination programmes elsewhere in Africa.

trial registrationISRCTN ISRCTN10926858 . Registered 21 December 2016. Retrospectively registered.

Indexed as

SeasonsAdultAlbendazoleAnimalsAnthelminticsChildChild, PreschoolCluster AnalysisCote d'IvoireDisease EradicationFemaleHumansMaleMiddle AgedNiclosamidePraziquantelAlbendazoleAnthelminticsNiclosamidePraziquantelSoilBulinus spp.Chemical snail controlCôte d’IvoireMass drug administrationNiclosamidePraziquantelSchistosoma haematobiumSeasonal transmissionSoil-transmitted helminthiasis

Identifiers

PMID29378542
PMCPMC5789673
OpenAlexW2789443997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.